State of Wisconsin Investment Board
APGE

State of Wisconsin Investment Board’s Apogee Therapeutics APGE Stock Holding History

State of Wisconsin Investment Board’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Sell
5,112
-15,344
-75% -$1.38M ﹤0.01% 1970
2026
Q1 		$1.72M Buy
20,456
+143
+0.7% +$10.4K ﹤0.01% 1459
2025
Q4 		$1.53M Buy
20,313
+12,218
+151% +$770K ﹤0.01% 1509
2025
Q3 		$322K Sell
8,095
-4,210
-34% -$161K ﹤0.01% 2078
2025
Q2 		$534K Buy
12,305
+3,814
+45% +$145K ﹤0.01% 1825
2025
Q1 		$317K Sell
8,491
-4,902
-37% -$190K ﹤0.01% 1946
2024
Q4 		$607K Buy
13,393
+5,201
+63% +$265K ﹤0.01% 1721
2024
Q3 		$481K Sell
8,192
-1,233
-13% -$59.1K ﹤0.01% 1887
2024
Q2 		$371K Sell
9,425
-661
-7% -$32.1K ﹤0.01% 1962
2024
Q1 		$670K Sell
10,086
-3,700
-27% -$162K ﹤0.01% 1594
2023
Q4 		$385K Buy
+13,786
New +$276K ﹤0.01% 1902

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

State of Wisconsin Investment Board's APGE Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Apogee Therapeutics (APGE) stake by 75% in Q2 2026, selling an estimated $1.38M and leaving 5,112 shares worth $679K. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

State of Wisconsin Investment Board first reported a position in APGE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.72M in Q1 2026. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • State of Wisconsin Investment Board held 5,112 shares of Apogee Therapeutics worth $679K as of Q2 2026.
  • State of Wisconsin Investment Board sold 15,344 Apogee Therapeutics shares in Q2 2026, an estimated $1.38M.
  • Apogee Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1970 holding.
  • State of Wisconsin Investment Board first reported a position in Apogee Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • State of Wisconsin Investment Board's Apogee Therapeutics position peaked at $1.72M in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.